Proqr Therapeutics
(PRQR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,289 | -33,797 | -22,769 | -11,245 | -23,130 |
| Depreciation Amortization | 1,378 | 1,091 | 784 | 369 | 530 |
| Other Working Capital | 1,586 | -615 | 1,459 | 55 | 700 |
| Other Operating Activity | 2,457 | 3,306 | 2,337 | 2,253 | -5,000 |
| Operating Cash Flow | $-37,869 | $-30,015 | $-18,189 | $-8,569 | $-26,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,810 | -2,784 | -2,342 | -554 | -1,430 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -40 |
| Investing Cash Flow | $-2,810 | $-2,784 | $-2,342 | $-554 | $-1,470 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 409 | 215 | 218 | 213 | N/A |
| Common Stock Issued | 2 | 2 | 2 | N/A | N/A |
| Other Financing Activity | -17 | -17 | -17 | -9 | 1,790 |
| Financing Cash Flow | $395 | $201 | $203 | $204 | $1,790 |
| Exchange Rate Effect | 817 | -819 | -631 | -1,450 | 6,730 |
| Beginning Cash Position | 104,978 | 105,869 | 107,160 | 104,655 | 125,180 |
| End Cash Position | 65,511 | 72,452 | 86,201 | 94,287 | 105,330 |
| Net Cash Flow | $-39,467 | $-33,418 | $-20,959 | $-10,368 | $-19,840 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,869 | -30,015 | -18,189 | -8,569 | -26,900 |
| Capital Expenditure | -2,810 | -2,784 | -2,342 | -554 | N/A |
| Free Cash Flow | -40,679 | -32,799 | -20,531 | -9,122 | -26,900 |